Skip to main content

Table 1 Comparison of odds and estimated annual percentage change (EAPC)

From: Quantifying temporal trends of age-standardized rates with odds

  Male Female
Sitea Odds
Median (1Q; 3Q)
EAPC
Median (1Q; 3Q)
Concordance (%) Odds
Median (1Q; 3Q)
EAPC
Median (1Q; 3Q)
Concordance (%)
All sites but non-melanoma skin 1.18 (1.1; 1.29) 0.83 (0.43; 1.13) 85 1.21 (1.13; 1.39) 0.71 (0.44; 1.17) 85
Prostate 1.43 (1.22; 1.67) 4.38 (3.14; 5.73) 95    
Breast     1.24 (1.15; 1.46) 1.52 (0.96; 2.11) 88
Stomach 0.79 (0.66; 0.87) −2.42 (− 3.08; − 1.79) 91 0.83 (0.71; 0.90) − 2.40 (− 3.20; − 1.64) 82
Lung 0.92 (0.77; 1.02) − 1.22 (− 1.80; 0.11) 76 1.17 (1.09; 1.33) 1.98 (0.98; 3.56) 78
Cervix uteri     0.85 (0.79; 0.94) −2.46 (− 3.44; − 1.08) 76
Thyroid 1.10 (1.05; 1.18) 2.75 (1.52; 4.27) 69 1.18 (1.11; 1.34) 3.46 (2.11; 5.54) 84
Kidney etc. 1.16 (1.08; 1.25) 1.93 (1.46; 2.70) 81 1.12 (1.07; 1.18) 2.05 (1.22; 2.45) 70
Non-Hodgkin Lymphoma 1.14 (1.08; 1.21) 1.91 (1.31; 2.44) 75 1.17 (1.10; 1.24) 2.06 (1.43; 2.83) 77
Melanoma of skin 1.22 (1.07; 1.45) 3.46 (2.01; 4.77) 75 1.17 (1.06; 1.32) 2.89 (1.25; 4.37) 70
Liver 1.14 (1.07; 1.27) 2.70 (0.97; 3.67) 78 1.07 (1.01; 1.15) 1.75 (−0.04; 3.01) 54
Colon 1.09 (1.01; 1.25) 0.85 (− 0.01; 2.36) 69 1.04 (0.97; 1.18) 0.29 (−0.38; 1.94) 62
Corpus uteri     1.10 (1.01; 1.19) 0.95 (−0.02; 1.84) 62
Oral cavity & pharynx 0.96 (0.88; 1.02) −0.67 (−1.6; 0.14) 62 1.04 (0.96; 1.09) 0.64 (−0.92; 1.56) 53
Ovary/other uterine adnexa     0.99 (0.94; 1.05) −0.29 (− 0.74; 0.54) 50
Esophagus 1.00 (0.92; 1.09) −0.15 (−1.84; 1.33) 59 0.99 (0.92; 1.04) −0.34 (−2.13; 0.86) 40
Rectum and anus 1.06 (1.00; 1.15) 0.69 (−0.07; 1.51) 55 1.03 (1.00; 1.09) 0.35 (−0.20; 0.9) 42
Larynx 0.92 (0.84; 0.97) −1.85 (−2.50; −0.71) 61 1.00 (0.95; 1.03) −0.47 (−2.21; 1.06) 29
Bladder 1.04 (0.99; 1.11) 0.39 (−0.16; 1.44) 47 1.03 (0.99; 1.09) 0.44 (−0.33; 1.50) 40
Pancreas 1.02 (0.97; 1.06) 0.10 (−0.50; 1.02) 44 1.05 (1.01; 1.10) 0.51 (0.04; 1.81) 36
Leukemia 1.03 (1; 1.07) 0.29 (−0.04; 0.88) 31 1.04 (1.00; 1.08) 0.48 (0.03; 0.98) 37
Brain and central nervous system 1.03 (1; 1.07) 0.49 (−0.13; 0.97) 33 1.03 (1.00; 1.06) 0.54 (−0.07; 1.36) 32
  1. aCancer sites were ordered by the percentage concordance in the significance between the odds from rank-ordered logit and EAPC from the weighted linear regression of log-transformed rates, which indicates the strength and persistence of evidence of a temporal trend across the 118 populations in CI5plus. Abbreviations: 1Q First quartile, 3Q Third quartile